SSDI EligibilityWho qualifies for SSDI, and how SSA actually decides. Check my eligibility

Fibromyalgia and SSDI: What Ruling 12-2p Requires

Fibromyalgia can qualify for Social Security Disability Insurance (SSDI), but the Social Security Administration (SSA) will not weigh how limiting the condition is until the condition itself is proven. Social Security Ruling (SSR) 12-2p, effective July 25, 2012, spells out the exact evidence SSA needs before fibromyalgia counts as a medically determinable impairment. Because the Blue Book contains no listing for fibromyalgia, claims succeed through medical equivalence or, far more often, through a residual functional capacity (RFC) assessment at steps 4 and 5 of the sequential evaluation.

Why Fibromyalgia Is Treated Differently

Fibromyalgia produces widespread pain, fatigue, unrefreshing sleep, morning stiffness, and difficulty with concentration and memory. Yet routine laboratory work and imaging in people with fibromyalgia are usually normal, and SSR 12-2p recognizes that no single laboratory test confirms the diagnosis.

That creates a proof problem. SSA's regulations require an impairment resulting from anatomical, physiological, or psychological abnormalities that can be shown by medically acceptable clinical and laboratory diagnostic techniques, as 20 CFR 404.1521 and 404.1508 describe. A statement of symptoms, no matter how sincere, can never establish disability by itself. SSR 12-2p applies that principle and then lists the specific clinical findings SSA will accept for this condition.

The Baseline Requirements

SSR 12-2p establishes fibromyalgia as a medically determinable impairment only when all of the following are documented in the medical evidence from an acceptable medical source under 20 CFR 404.1513:

  1. A physician experienced in the diagnosis and treatment of fibromyalgia diagnosed the condition.
  2. The medical records show a history of widespread pain, meaning pain in all four quadrants of the body plus the axial skeleton, that has persisted for at least 3 months.
  3. The records document either the tender point findings or the revised scoring criteria described below.

A family doctor's note that simply says "fibromyalgia" satisfies none of this by itself. The ruling makes clear that the diagnosis must rest on the physician's own examination findings, not only on the claimant's report of symptoms.

Path One: Eleven of Eighteen Tender Points

The first evidentiary path comes from the 1990 American College of Rheumatology criteria. On physical examination by digital palpation, at least 11 of 18 specified tender point sites must be positive. The sites occur in pairs on both sides of the body, above and below the waist: the occiput, low cervical region, trapezius, supraspinatus, second rib, lateral epicondyle, gluteal, greater trochanter, and knee.

Pain on digital palpation must be present in at least 11 of these sites for the finding to count. Because the sites are bilateral and distributed above and below the waist, a properly performed examination also demonstrates that the pain is widespread rather than localized.

Path Two: The 2010 ACR Criteria

The second path reflects the 2010 revision of the American College of Rheumatology criteria, which replaced the tender point count with a symptom-based score. Under SSR 12-2p, this path requires evidence of all three of the following:

  1. A history of widespread pain.
  2. Repeated manifestations of six or more associated symptoms, signs, or co-occurring conditions. The ruling names fatigue, waking unrefreshed, cognitive problems, irritable bowel syndrome, headache, and depression as examples.
  3. Objective medical evidence, such as a detailed physical examination, that documents the findings.

The objective evidence must show either a widespread pain index (WPI) of 7 or more with a symptom severity (SS) scale score of 5 or more, or a WPI of 3 to 6 with an SS score of 9 or more. Under the 2010 ACR criteria those symptoms must have persisted at that level for at least 3 months, and no other disorder must fully explain the pain.

What Cannot Establish the Impairment

SSR 12-2p is explicit about what does not work. SSA cannot find a medically determinable impairment of fibromyalgia based solely on the claimant's statements. Normal laboratory tests do not rule the condition out, but they also cannot substitute for the required clinical findings.

The ruling also cautions that a physician's diagnosis alone, without the documented history and examination findings, is not sufficient. This is why a single visit note carries far less weight than longitudinal treatment records from a rheumatologist who has examined the claimant repeatedly over time.

After the Impairment Is Established

Once fibromyalgia is a medically determinable impairment, SSA applies the ordinary five-step sequential evaluation. At step 2 the impairment, alone or combined with others under 20 CFR 404.1523, must have more than a minimal effect on basic work activities and must last or be expected to last 12 continuous months under 20 CFR 404.1509.

At step 3 there is no listing to meet, so SSA asks whether the impairment, alone or in combination with another impairment, medically equals the severity of any listing under 20 CFR 404.1526. Equivalence findings in fibromyalgia cases are possible but uncommon.

At steps 4 and 5, SSA assesses RFC under 20 CFR 404.1545, which measures what the person can still do despite the impairments. Statements about pain, fatigue, and concentration are then evaluated under the two-step symptom analysis of 20 CFR 404.1529. Since SSR 16-3p took effect on October 25, 2016, the question is whether those statements are consistent with the entire record, not a subjective credibility judgment.

Fibromyalgia Plus Other Conditions

The ruling recognizes that fibromyalgia often travels with other medically determinable impairments, including inflammatory arthritis, lupus, chronic fatigue syndrome, irritable bowel syndrome, anxiety, and depression. Under the combined effects rule in 20 CFR 404.1523, SSA must consider the limiting effects of all impairments together even if no single one is severe on its own.

This matters in practice because fatigue and cognitive difficulty, which the RFC should capture, may stem from several conditions at once. A treating source who explains how the whole cluster of impairments limits function gives the adjudicator what the regulations require.

Building the Record

The strongest fibromyalgia records share a few features. Care comes from a physician, ideally a rheumatologist, experienced with the condition, and visits occur regularly over many months. Each examination documents the actual findings, including tender point results or symptom scale scores, rather than restating the diagnosis. Treatment notes describe the response to medication, including side effects, and any attempts at exercise, therapy, or sleep treatment.

Statements from family members, former employers, and others who see the person regularly can help show day-to-day function over time. None of this guarantees an approval, but without the baseline proof SSR 12-2p demands, the claim never reaches the question of severity at all.

Frequently Asked Questions

Is there a Blue Book listing for fibromyalgia? No. SSR 12-2p confirms fibromyalgia has no listing, so a claim proceeds by medical equivalence under 20 CFR 404.1526 or, more often, through a residual functional capacity assessment at steps 4 and 5.

What are the two ways to prove fibromyalgia as a medically determinable impairment? SSR 12-2p accepts either at least 11 of 18 positive tender points on physical examination, or the 2010 American College of Rheumatology criteria using the widespread pain index and symptom severity scale. Both paths also require a knowledgeable physician's diagnosis and at least 3 months of widespread pain.

Can you win SSDI on fibromyalgia alone? Yes. SSR 12-2p states that fibromyalgia, alone or together with other impairments, can medically equal a listing or support a finding that you cannot work based on residual functional capacity.

This article is general information about SSDI eligibility, not legal advice. Program rules and evaluation policies change over time, and every case turns on its own medical evidence. Consult a qualified representative or contact SSA directly for guidance on a specific claim.

Common questions

Is there a Blue Book listing for fibromyalgia?

No. SSR 12-2p confirms fibromyalgia has no listing, so a claim proceeds by medical equivalence under 20 CFR 404.1526 or, more often, through a residual functional capacity assessment at steps 4 and 5.

What are the two ways to prove fibromyalgia as a medically determinable impairment?

SSR 12-2p accepts either at least 11 of 18 positive tender points on physical examination, or the 2010 American College of Rheumatology criteria using the widespread pain index and symptom severity scale. Both paths also require a knowledgeable physician's diagnosis and at least 3 months of widespread pain.

Can you win SSDI on fibromyalgia alone?

Yes. SSR 12-2p states that fibromyalgia, alone or together with other impairments, can medically equal a listing or support a finding that you cannot work based on residual functional capacity.

This page is general information about the Social Security Disability Insurance program, not legal advice. SSA rules and figures change. Confirm anything that affects your claim with SSA directly or with a qualified representative.